Celebrex capsules

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

celecoxib

Available from:

R-Pharm Germany GmbH

ATC code:

M01AH01

INN (International Name):

celecoxib

Dosage:

200mg

Pharmaceutical form:

capsules

Units in package:

(20/2x10/) in blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2018-01-10

Patient Information leaflet

,,,.,,,
;
:..,,,,,,,.,,.,;,,,,.,,....,
.ISICTF
tro
IrpEMeHeHruo
nercapcmenuoro
fipefiapaTa
Anfl
MeAEr${Ecraorc
EpErreffeHnc
'
,
uEJrEBnEKcCI
='4-*4
,tl
'",""t.",
'
f
oprorde,
narEame:
I{e*e6petC@
nawry{noAsoe
*.orrerrropgunoe
rraBEaHHff
qenexorcud
.ltenapcrnmur
6op*u
t
Ka$cyrrbr
Cosras
(ni
1
raneyry):
Arrfinsoo
eeuiecreo:
qerexoKcub
_
100
tvtr
HrrH
200
ur.
.l
I&nryaat
100
ne;w
200
Aiz
naoHo:ruapar
l+g,'l
ut/+:g,g
mr,
Harprur
nayplrJrcyJr'sar
grr
r*r/g,l
*",
no""o*
*ro
6,8
wr/6,7
*",
rcpo"oapr*o*u
i{arpm
z,7
ur/z,v
Mr,.MarH}rfl
creapar
z,T
rwrlz,}
*r,
uoorroor,
TRTaIra
ApIoKcHn
oKoJIo
1,7
Mry
xenaTl'rx
oKoJIo
58,3
nar.
QepHHJla
Arrrr
Kancyn
100
prr
(uepulma
ronydue
S'8-6018)
co.4eplKar:
IIIeirIttK
22-27
Yo,
?Tanon
33'38
04,
raroqporarroJr
0,5-4
o/o,
byranon
4-8
Vn,
npontluexrrnronr
3-6
7o,
arvuax
soAnrrft
l-2
Ya,JraK
afiron{I{snesrfr
rorydofi
FD&C
ei"J
re
rr.
"o*"tri.p*dr"""
Etrryrorfirra
(Et3Z)
Z4-Zg,o/o,itepnuna
gnx
r€rrcy:r
ZOO
*,
(qepmanaX"*ur"
Se-iOOZl
coAepxar:
merrr{ap
Z2-ZTolo,3tano-n,r-rU
*,
*"*;;;;
nSt
I
Jlu,
6yraHon
4'g
yo,
ffponHJlel{flI}rrconr
3-6
7o,
auunax
noAHrd
l-2
oil,nouarr"o,
xeJre3a
oo"*
xe.nrrrft
{El7
z)
l
g-Zz
o/o.
:l;.
o
rm
,,,:,...
no"
roqrr.r
MryrofPoBxSMI{.6en5giEAa
m*yg
,
.*a*,
(I00})
qacTH
xancyJrbr.
Kancyla
?00
ur:
Herpospaqnax
6etas
IIJITa
florrru
uaprapon
u
6e.unrrrr
rna
x**"ur
noJrocxax:
(200>l
66tr
,
TBep#afi
ll{gJraTuuonfirr
Karrcyna
c
-
rra
oflxo:ff,qac:rH
*t

-
na
4pyroff
rracrE
RafieyJrbr.
Cogepxmro"**ryo,
rparymr
6e.rroro
EJIE
rroqTa
Geroro
uBera.
OAPMAfiOTEPAIIEBTfiIIECKAII
fpyIIIIA:
Eectepoglsrrtr
uporreoeocrrarj{rerrbnrr*
EpeffiF
GITBID-
KirnATFftrlA}I{ll
OAP@C]tsOEETBA
OWtw
n+i
|
--
l.
Ife:rerorcca6
olxaaaer
nporxcoBocnffrr,ITer!;rllrl{?
o6e:6ori:anamrrr{tr{
H
iKaporToH}DKarcspr.\{
.IIeicrBEeM:
d.noxapyx
o6pasonaune
BocnarluTeJrbnbrx
[pocrarnaH.{riHoB
(Pg)
s
ocHoBHo\{
3a
c'{er
asru6lrpoBaar.rt
qI{KJIooKcHreHassr-2
(qOf-?).
tr4ngynqltx
qof-2
npoucxo,1ar
B
orBer
Ha
BocnaleHlle
u
n

Summary of Product characteristics

Odurax
Xn;*amtephmnlca
Jlercapcrea
6orrn).
Jle.{erae
repea.moE
.wcMenopeg.
4e
Ctroeo6br
trprrireflenufl
R
Ao3bl
B46pa
"e
pasxeasmar,
garruBarr
eogofi,
He3aBuclrMo
or
trpr,rervra,lrsrrpr.,
t1,.{L{r
?y't)rz-/7
Ilocxo-rug.-
prdcK
Bo3Mo)KtrrJX
ocnuxr*slrsfi
co
cropoubl
cepAertno-cocyAncroE
cHcreMLI
lloxer
Bo3pacrarb
c
)Berrrlqeur.rel{
gos6l
i.r
EpoAoJI}I{r,ITefibI-IocTl{
npuel{a
iTpelapara
I{e:reSpexcs.
cro
c..IetryeT
trpHMerrrTb
Mr{I{}rMalIbIr0
Bo3MOX$lErM KOpOTI{H}I
KypAOM
B
I{!IHHb'Ia[bAO
r$$exrI{Buofi
,ao3e
rrpetrapara.
MaxcaMaJrsuag
pexoMeuilona'I{Haa
cyrotrHas
Ao3a
rrpr{
Anr4TenbHolu
[pxe]\te
-
400
ur.
cu'trnnto*ramwrccKoe
fii\etftte
acmeo&pfi1pi'')31l"
peKoMeHAoBaHHas
'{o3a
coeraB'[get
200
Mr
s
cyrKli
:a
1
zrm
2
npi-reua.
Cunrnmo*ran'nfiect{oe
reLreHua
pelttamoudruoeo
Lrpnrpumd.'
peKoMe}I.[oBaHHat
Ao3a
llenexoxclr6a
cocraB.rrf,el 100
u.rilr
200
ur
2
pa:a
B
cyrnl{.
CuttnmonamrtqecKoe
reuerrue
cul^unollttr]ylol4eeo
cnondunurna:
peKoMgr{.{oBaeHatl
Ao3a
qeneroxsa6a
coc"a*nFrer
200
b{r
E
c},Tnpr
sa
I
trxv"
2
upuel{a.
V
ueroropblx
ilaqfiel{ToB
orMeqeHa
e$sertarriocrl
npxmel{eil}I{
400
ur
B
cyrnn.
Jleqetge
6oneeoea
crtndpotttt;per(oMeHloBauna.ri
Ha.radbaa.s
.qo3a
l{eneKorcu6a
coc'rasJiasr
400
hrr)
c
rtrocre.{y}our"rh{,
upu
ueo6xo.flRmocru,
rrpueMord
AonoJigaTerssofi
J{osr;I
B 200
ur,
n
neprrrft
Aeur,,
B
fiocnegyror$Hs
AI{r{
peEoMeHAOBaH}"IaJr
Ao3a
cocrar:*ret
200
mr
2
pa:a
B
cyrrrr,
rr0
H€O6XOAnlvroClrH"
Jleve*ure
nepauwtaii
,ucaettopeel..
peKoMe11AoBaHHasi
Haqanr,Has
Ao3a
r{eJleKoxcuba
cocTaB]IrieT
400
rrer,
c
nocJregylolqr{r\,L
npn
neodxonnturccrl4,
IIpHeMo[,r
AorlottHnrennsoit
,{o31,I
B 200
Nrr,
s
nepnrrfi
gena.
B
nocnegylotqne
AHr,r
peKoM€II'4oBaHHas
Ao3a
cocraBrifier
200
Mr
2
pa:a
B
oyrKll,
no
Heo6xagnmocrtl.
r.
flo_xstlre
nauuenxr,i:
o6trmc
KoppeKurm
AG3br
lre
rpe6ye:rcl.
Ognuco
y
flaq]Ierrop
c
lraccofi
texa
Hr.txe
50
Nr
ne*regr{e
Jrf{Hre
r{aqHr{arb
c
r{Hrlr{N{aJlsuoft
pexomesAonauncfi.qosbl
Hapltuenue
dtygrcuwu
neqerilt:
y
naquer{Tots
c
lerxoii'
crenenblo
rt}I(ecrkl
ne'{enoqFlofi
HeAoerarorrHocrr.r
(i

Read the complete document